Google's health startup forges venture with AbbVie
The alliance announced Wednesday calls for Google Inc. and AbbVie Inc. to each invest $250 million in the project. They will split all expenses and any profits generated by the venture.
Calico, a company created by Google last year, will manage a team of scientists who will work at a research-and-development lab in the San Francisco Bay Area. The precise location and size of the new lab hasn't been determined.
AbbVie, a spin-off from Abbott Laboratories, will oversee the marketing of the drugs.
Calico is run by former Genentech CEO Arthur Levinson.
Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.